Showing 1 - 10 of 30
This article uses data on transactions in the pharmaceutical industry to examine the demand-side of technology outsourcing. By integrating a transaction-cost economics perspective with the analysis of internal R&D capabilities, we find that firms with relatively more cospecialized complementary...
Persistent link: https://www.econbiz.de/10013038800
This paper uses data on transactions in the pharmaceutical industry to examine the demand-side of technology outsourcing. By integrating a transaction-cost economics perspective with the analysis of internal Ramp;D capabilities, we find that firms with relatively more cospecialized complementary...
Persistent link: https://www.econbiz.de/10012707435
Persistent link: https://www.econbiz.de/10003349703
Persistent link: https://www.econbiz.de/10003975947
Persistent link: https://www.econbiz.de/10010433285
Persistent link: https://www.econbiz.de/10009297006
Persistent link: https://www.econbiz.de/10013270327
Are CEOs' attitudes and beliefs linked to their fims' innovative performance? This paper uses Malmendier and Tate's measure of overconfidence, based on CEO stock-option exercise, to study the relationship between a CEO's "revealed beliefs" about future performance and standard measures of...
Persistent link: https://www.econbiz.de/10012462611
We exploit a change in eligibility rules for the Canadian Scientific Research and Experimental Development (SRED) tax credit to gain insight on how tax credits impact small-firm R&D expenditures. After a 2004 program change, privately owned firms that became eligible for a 35 percent tax credit...
Persistent link: https://www.econbiz.de/10012458050
Persistent link: https://www.econbiz.de/10014328950